BETA


2005/2621(RSP) Resolution on patents for biotechnological inventions

Progress: Procedure completed

Legal Basis:
RoP 132-p2

Events

2005/10/26
   EP - Text adopted by Parliament, topical subjects
Details

The European Parliament adopted a resolution on patents for biotechnological inventions and expressed its s upport for biotechnology as a future technology. An appropriate political framework is important to support this technology, also taking account of ethical, environmental and health aspects. The patenting of biotechnological inventions in accordance with common rules throughout Europe is an important precondition for the provision in Europe of appropriate support for this future technology.

Parliament stated that it supported further stem-cell research and other alternatives to promote human health. It did, however, underline its fundamental position regarding the application of biotechnology to human beings, especially the rejection of interventions in the human germ line, the rejection of cloning of the human being in all phases of its development and the rejection of research on human embryos, which destroys the embryo. Directive 98/44/EC provides the framework for this in most cases, but it still leaves important questions open, such as the patenting of human DNA. Parliament called on the European Patent Office and the Member States to grant patents on human DNA only in connection with a concrete application and for the scope of the patent to be limited to this concrete application so that other users can use and patent the same DNA sequence for other applications (purpose-bound protection). The Commission must examine whether this interpretation of the Directive can be achieved by means of a recommendation to the Member States or whether it requires an amendment to the Directive.

Parliament went on to recall that the European Patent Office granted a patent on 2 February 2005 (EP1257168) that includes a method of selection of human germ cells and of the germ cells themselves. Opposition has been made to this decision, so that the legal situation is still unclear. Parliament pointed out that germ cells are not patentable as part of the human body and certainly not an invention, and that patent EP1257168 therefore constitutes an infringement of the Directive. It asked the Commission to file a notice of opposition to patent EP1257168 without delay. It called on the European Patent Office, the Commission and the competent authorities in the Member States to work together with Parliament to confirm that all kinds of human cloning are excluded from patenting under the Directive.

Parliament insisted that the creation of human embryonic stem cells implies the destruction of human embryos and that therefore the patenting of procedures involving human embryonic stem cells or cells that are grown from human embryonic stem cells is a violation of Article 6(2(c) of the Directive. The European Patent Office is asked to set up a further body which, because of the sensitivity of the issue, checks patents that are sensitive from an ethical point of view before they are granted .

2005/10/26
   EP - Results of vote in Parliament
2005/10/26
   EP - Decision by Parliament
Details

The European Parliament adopted a resolution on patents for biotechnological inventions and expressed its s upport for biotechnology as a future technology. An appropriate political framework is important to support this technology, also taking account of ethical, environmental and health aspects. The patenting of biotechnological inventions in accordance with common rules throughout Europe is an important precondition for the provision in Europe of appropriate support for this future technology.

Parliament stated that it supported further stem-cell research and other alternatives to promote human health. It did, however, underline its fundamental position regarding the application of biotechnology to human beings, especially the rejection of interventions in the human germ line, the rejection of cloning of the human being in all phases of its development and the rejection of research on human embryos, which destroys the embryo. Directive 98/44/EC provides the framework for this in most cases, but it still leaves important questions open, such as the patenting of human DNA. Parliament called on the European Patent Office and the Member States to grant patents on human DNA only in connection with a concrete application and for the scope of the patent to be limited to this concrete application so that other users can use and patent the same DNA sequence for other applications (purpose-bound protection). The Commission must examine whether this interpretation of the Directive can be achieved by means of a recommendation to the Member States or whether it requires an amendment to the Directive.

Parliament went on to recall that the European Patent Office granted a patent on 2 February 2005 (EP1257168) that includes a method of selection of human germ cells and of the germ cells themselves. Opposition has been made to this decision, so that the legal situation is still unclear. Parliament pointed out that germ cells are not patentable as part of the human body and certainly not an invention, and that patent EP1257168 therefore constitutes an infringement of the Directive. It asked the Commission to file a notice of opposition to patent EP1257168 without delay. It called on the European Patent Office, the Commission and the competent authorities in the Member States to work together with Parliament to confirm that all kinds of human cloning are excluded from patenting under the Directive.

Parliament insisted that the creation of human embryonic stem cells implies the destruction of human embryos and that therefore the patenting of procedures involving human embryonic stem cells or cells that are grown from human embryonic stem cells is a violation of Article 6(2(c) of the Directive. The European Patent Office is asked to set up a further body which, because of the sensitivity of the issue, checks patents that are sensitive from an ethical point of view before they are granted .

Documents
2005/10/26
   EP - End of procedure in Parliament
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   EP - Motion for a resolution
Documents
2005/10/25
   Joint motion for resolution
Documents
2005/10/25
   EP - Debate in Parliament

Documents

Votes

RC B6-0551/2005 - Biotechnologies - am. 7 #

2005/10/26 Outcome: +: 379, -: 231, 0: 18
DE IT PL CZ IE LV SK ES EL HU LU GB AT CY FR SI LT SE FI MT BE PT NL EE DK
Total
82
57
47
23
12
9
13
47
22
19
6
65
16
5
70
6
12
17
13
5
22
20
22
5
13
icon: PPE-DE PPE-DE
231

Luxembourg PPE-DE

3

Austria PPE-DE

Abstain (1)

4

Cyprus PPE-DE

2
2
3

Malta PPE-DE

2

Estonia PPE-DE

For (1)

1

Denmark PPE-DE

For (1)

1
icon: Verts/ALE Verts/ALE
36

Italy Verts/ALE

1

Latvia Verts/ALE

1

Spain Verts/ALE

Abstain (1)

3

Luxembourg Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5

Austria Verts/ALE

2

Sweden Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Netherlands Verts/ALE

Abstain (1)

3

Denmark Verts/ALE

For (1)

1
icon: GUE/NGL GUE/NGL
35

Ireland GUE/NGL

1

Spain GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1

Cyprus GUE/NGL

2

France GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Finland GUE/NGL

For (1)

1

Portugal GUE/NGL

For (1)

3

Netherlands GUE/NGL

For (1)

1
icon: UEN UEN
21

Ireland UEN

3

Lithuania UEN

2

Denmark UEN

For (1)

1
icon: NI NI
26

Italy NI

Against (1)

3

Czechia NI

1

Slovakia NI

Abstain (1)

2

United Kingdom NI

Against (1)

Abstain (1)

4

Austria NI

2
icon: IND/DEM IND/DEM
30

Czechia IND/DEM

1

Ireland IND/DEM

For (1)

1

Sweden IND/DEM

3

Netherlands IND/DEM

2

Denmark IND/DEM

Abstain (1)

1
icon: ALDE ALDE
77

Ireland ALDE

For (1)

1

Latvia ALDE

Against (1)

1

Spain ALDE

Abstain (1)

2

Hungary ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Austria ALDE

1

Cyprus ALDE

Against (1)

1

Slovenia ALDE

Against (1)

1

Sweden ALDE

2

Estonia ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4
icon: PSE PSE
172

Czechia PSE

2

Ireland PSE

Against (1)

1

Slovakia PSE

3

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Finland PSE

3

RC B6-0551/2005 - Biotechnologies - am. 2 #

2005/10/26 Outcome: -: 333, +: 287, 0: 24
SE GB DK FI LT BE EE PT CY EL MT NL SI ES LU SK AT LV FR CZ HU IE IT PL DE
Total
17
70
13
13
12
22
6
20
5
23
5
23
6
47
6
13
17
9
70
23
19
12
59
50
84
icon: PSE PSE
176

Lithuania PSE

2

Slovenia PSE

For (1)

1

Luxembourg PSE

For (1)

1

Czechia PSE

2

Ireland PSE

1
icon: ALDE ALDE
80

Sweden ALDE

2
4

Estonia ALDE

2

Cyprus ALDE

For (1)

1

Slovenia ALDE

1

Spain ALDE

Abstain (1)

2

Luxembourg ALDE

For (1)

1

Austria ALDE

Against (1)

1

Latvia ALDE

1

Hungary ALDE

1

Ireland ALDE

Against (1)

1
icon: GUE/NGL GUE/NGL
35

Sweden GUE/NGL

1

United Kingdom GUE/NGL

1

Finland GUE/NGL

For (1)

1

Portugal GUE/NGL

3

Cyprus GUE/NGL

2

Netherlands GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

France GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

1
icon: NI NI
26

United Kingdom NI

Abstain (1)

4

Belgium NI

3

Slovakia NI

Abstain (1)

2

Austria NI

2

Czechia NI

Abstain (1)

1

Italy NI

Against (1)

Abstain (1)

3
icon: UEN UEN
23

Denmark UEN

Abstain (1)

1

Lithuania UEN

2

Ireland UEN

3
icon: IND/DEM IND/DEM
30

Sweden IND/DEM

3

Denmark IND/DEM

1

Netherlands IND/DEM

2

Czechia IND/DEM

Against (1)

1

Ireland IND/DEM

Against (1)

1
icon: Verts/ALE Verts/ALE
37

Sweden Verts/ALE

Against (1)

1

United Kingdom Verts/ALE

5

Denmark Verts/ALE

Against (1)

1

Finland Verts/ALE

Against (1)

1

Belgium Verts/ALE

2

Spain Verts/ALE

2

Luxembourg Verts/ALE

Against (1)

1

Austria Verts/ALE

2

Latvia Verts/ALE

Against (1)

1

Italy Verts/ALE

Against (1)

1
icon: PPE-DE PPE-DE
237

Denmark PPE-DE

For (1)

1

Finland PPE-DE

3

Lithuania PPE-DE

2

Estonia PPE-DE

Against (1)

1

Cyprus PPE-DE

2

Malta PPE-DE

Against (2)

2

Slovenia PPE-DE

4

Luxembourg PPE-DE

3

Austria PPE-DE

Abstain (1)

5

Latvia PPE-DE

3

Ireland PPE-DE

For (1)

5

RC B6-0551/2005 - Biotechnologies - am. 19/1 #

2005/10/26 Outcome: +: 318, -: 299, 0: 24
DE PL IT FR SK IE HU LU AT ES SI LV LT PT NL CY EL BE MT EE DK FI CZ SE GB
Total
82
50
58
69
13
12
19
6
17
48
6
9
12
20
23
5
23
23
5
6
12
13
23
17
70
icon: PPE-DE PPE-DE
237

Ireland PPE-DE

Against (1)

5

Luxembourg PPE-DE

3
2

Cyprus PPE-DE

2

Malta PPE-DE

2

Estonia PPE-DE

For (1)

1

Denmark PPE-DE

Against (1)

1

Finland PPE-DE

3
icon: Verts/ALE Verts/ALE
38

Italy Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Latvia Verts/ALE

1

Belgium Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5
icon: UEN UEN
22

Ireland UEN

Abstain (1)

3

Lithuania UEN

2

Denmark UEN

For (1)

1
icon: NI NI
25

Italy NI

Against (1)

3

Slovakia NI

Abstain (1)

2

Austria NI

2

Czechia NI

Against (1)

1

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4
icon: IND/DEM IND/DEM
30

Ireland IND/DEM

For (1)

1

Netherlands IND/DEM

2

Denmark IND/DEM

1

Czechia IND/DEM

Against (1)

1

Sweden IND/DEM

3
icon: GUE/NGL GUE/NGL
35

France GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

Against (1)

1

Spain GUE/NGL

Against (1)

1

Portugal GUE/NGL

Against (1)

3

Netherlands GUE/NGL

Against (1)

1

Cyprus GUE/NGL

2

Finland GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

United Kingdom GUE/NGL

Against (1)

1
icon: ALDE ALDE
79

Ireland ALDE

For (1)

1

Hungary ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Austria ALDE

1

Spain ALDE

Abstain (1)

2

Slovenia ALDE

Against (1)

1

Latvia ALDE

Against (1)

1

Cyprus ALDE

Abstain (1)

1

Estonia ALDE

Against (2)

2

Denmark ALDE

Abstain (1)

4

Sweden ALDE

2
icon: PSE PSE
175

Slovakia PSE

3

Ireland PSE

Against (1)

1

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Finland PSE

3

Czechia PSE

2

RC B6-0551/2005 - Biotechnologies - am. 19/2 #

2005/10/26 Outcome: -: 527, +: 76, 0: 36
LU CY AT LV MT IE SI EE DK FI LT SK NL BE PT SE HU EL CZ PL FR ES IT DE GB
Total
6
5
17
9
5
12
6
6
12
13
12
13
23
22
19
17
19
22
23
50
70
47
58
83
70
icon: Verts/ALE Verts/ALE
38

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Latvia Verts/ALE

1

Denmark Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Sweden Verts/ALE

For (1)

1

Italy Verts/ALE

1

United Kingdom Verts/ALE

5
icon: NI NI
26

Austria NI

2

Slovakia NI

2

Czechia NI

Against (1)

1

Italy NI

Against (1)

3

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4
icon: IND/DEM IND/DEM
30

Ireland IND/DEM

For (1)

1

Denmark IND/DEM

1

Netherlands IND/DEM

2

Sweden IND/DEM

3

Czechia IND/DEM

Against (1)

1

Italy IND/DEM

For (1)

3
icon: UEN UEN
23

Ireland UEN

For (1)

3

Denmark UEN

Against (1)

1

Lithuania UEN

2
icon: GUE/NGL GUE/NGL
34

Cyprus GUE/NGL

2

Ireland GUE/NGL

Against (1)

1

Finland GUE/NGL

Against (1)

1

Netherlands GUE/NGL

Against (1)

1

Portugal GUE/NGL

Against (1)

3

Sweden GUE/NGL

Against (1)

1

France GUE/NGL

Abstain (1)

1

Spain GUE/NGL

Against (1)

1

United Kingdom GUE/NGL

Against (1)

1
icon: ALDE ALDE
79

Luxembourg ALDE

Against (1)

1

Cyprus ALDE

Abstain (1)

1

Austria ALDE

1

Latvia ALDE

Against (1)

1

Ireland ALDE

Against (1)

1

Slovenia ALDE

Against (1)

1

Estonia ALDE

Against (2)

2

Denmark ALDE

Abstain (1)

4

Sweden ALDE

2

Hungary ALDE

Against (1)

1
2
icon: PSE PSE
174

Luxembourg PSE

Against (1)

1

Ireland PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Finland PSE

3

Lithuania PSE

2

Slovakia PSE

3

Czechia PSE

2
icon: PPE-DE PPE-DE
235

Luxembourg PPE-DE

3

Cyprus PPE-DE

2

Austria PPE-DE

Abstain (1)

5

Latvia PPE-DE

3

Malta PPE-DE

Against (2)

2

Slovenia PPE-DE

4

Estonia PPE-DE

Against (1)

1

Denmark PPE-DE

Against (1)

1

Finland PPE-DE

3

Lithuania PPE-DE

2

RC B6-0551/2005 - Biotechnologies - am. 9 #

2005/10/26 Outcome: +: 325, -: 275, 0: 25
DE PL IT LV IE HU EL SK LU SI NL LT AT PT MT CY CZ BE DK EE FI ES SE FR GB
Total
80
50
57
9
11
18
20
12
6
5
22
11
15
19
5
5
23
22
12
6
13
48
17
68
71
icon: PPE-DE PPE-DE
235

Ireland PPE-DE

Against (1)

5

Luxembourg PPE-DE

3
2

Austria PPE-DE

Against (1)

Abstain (1)

5

Malta PPE-DE

2

Cyprus PPE-DE

2

Denmark PPE-DE

Against (1)

1

Estonia PPE-DE

For (1)

1

Finland PPE-DE

For (1)

3
icon: Verts/ALE Verts/ALE
37

Italy Verts/ALE

1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Belgium Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Spain Verts/ALE

Against (1)

3

Sweden Verts/ALE

For (1)

1

United Kingdom Verts/ALE

Abstain (1)

5
icon: UEN UEN
23

Ireland UEN

Abstain (1)

3

Lithuania UEN

Abstain (1)

2

Denmark UEN

Abstain (1)

1
icon: NI NI
24

Italy NI

Abstain (1)

3

Slovakia NI

Abstain (1)

2

Austria NI

For (1)

1

Czechia NI

1

Belgium NI

2

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4
icon: IND/DEM IND/DEM
30

Ireland IND/DEM

For (1)

1

Netherlands IND/DEM

2

Czechia IND/DEM

Abstain (1)

1

Denmark IND/DEM

1

Sweden IND/DEM

For (1)

3

France IND/DEM

2
icon: GUE/NGL GUE/NGL
33

Netherlands GUE/NGL

Against (1)

1

Portugal GUE/NGL

Abstain (1)

3

Cyprus GUE/NGL

2

Finland GUE/NGL

Against (1)

1

Spain GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

France GUE/NGL

Against (1)

1

United Kingdom GUE/NGL

1
icon: ALDE ALDE
76

Latvia ALDE

Against (1)

1

Ireland ALDE

For (1)

1

Hungary ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Austria ALDE

1

Cyprus ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4

Estonia ALDE

Against (2)

2

Spain ALDE

Abstain (1)

2

Sweden ALDE

2
icon: PSE PSE
167

Ireland PSE

Against (1)

1

Slovakia PSE

3

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Czechia PSE

2

Finland PSE

For (1)

3

RC B6-0551/2005 - Biotechnologies - am. 3 #

2005/10/26 Outcome: -: 306, +: 291, 0: 41
GB SE DK BE FI LT EE FR EL MT NL CZ ES SI AT PT CY LV IT SK IE LU HU PL DE
Total
71
17
12
23
13
12
6
68
23
5
23
24
45
6
16
20
5
9
58
13
12
5
19
50
83
icon: PSE PSE
172

Lithuania PSE

2

Czechia PSE

2

Slovenia PSE

For (1)

1

Ireland PSE

1
icon: ALDE ALDE
80

Sweden ALDE

Abstain (1)

2
4

Estonia ALDE

2

Slovenia ALDE

1

Austria ALDE

Against (1)

1

Cyprus ALDE

For (1)

1

Latvia ALDE

1

Ireland ALDE

Abstain (1)

1

Luxembourg ALDE

Abstain (1)

1

Hungary ALDE

1
icon: NI NI
26

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4

Czechia NI

1

Austria NI

Against (1)

Abstain (1)

2

Slovakia NI

Abstain (1)

2
icon: UEN UEN
22

Denmark UEN

For (1)

1

Lithuania UEN

2

Ireland UEN

3
icon: IND/DEM IND/DEM
31

Sweden IND/DEM

3

Denmark IND/DEM

1

Netherlands IND/DEM

2

Czechia IND/DEM

1

Ireland IND/DEM

Against (1)

1
icon: GUE/NGL GUE/NGL
34

United Kingdom GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

Finland GUE/NGL

Against (1)

1

France GUE/NGL

Against (1)

1

Netherlands GUE/NGL

Against (1)

1

Spain GUE/NGL

Against (1)

1

Portugal GUE/NGL

3

Cyprus GUE/NGL

2

Ireland GUE/NGL

Against (1)

1
icon: Verts/ALE Verts/ALE
37

United Kingdom Verts/ALE

5

Sweden Verts/ALE

Against (1)

1

Denmark Verts/ALE

Against (1)

1

Belgium Verts/ALE

2

Finland Verts/ALE

Against (1)

1

Spain Verts/ALE

2

Austria Verts/ALE

2

Latvia Verts/ALE

Against (1)

1

Italy Verts/ALE

Against (1)

1

Luxembourg Verts/ALE

Against (1)

1
icon: PPE-DE PPE-DE
236

Denmark PPE-DE

For (1)

1

Finland PPE-DE

Against (1)

3

Lithuania PPE-DE

2

Estonia PPE-DE

Against (1)

1

Malta PPE-DE

Against (2)

2

Slovenia PPE-DE

4

Austria PPE-DE

Abstain (1)

5

Cyprus PPE-DE

2

Latvia PPE-DE

3

Ireland PPE-DE

For (1)

5

Luxembourg PPE-DE

3

RC B6-0551/2005 - Biotechnologies - am. 4 #

2005/10/26 Outcome: -: 322, +: 276, 0: 37
GB SE FI DK FR BE EE PT LT CZ MT NL AT SI LV CY LU HU IE EL SK ES IT PL DE
Total
69
17
13
12
67
23
6
20
12
24
5
23
16
6
9
5
6
19
12
23
13
48
55
49
83
icon: PSE PSE
170

Lithuania PSE

2

Czechia PSE

2

Slovenia PSE

For (1)

1

Luxembourg PSE

For (1)

1

Ireland PSE

1
icon: ALDE ALDE
79

Sweden ALDE

Abstain (1)

2
4

Estonia ALDE

2

Austria ALDE

Against (1)

1

Slovenia ALDE

1

Latvia ALDE

1

Cyprus ALDE

For (1)

1

Luxembourg ALDE

Against (1)

1

Hungary ALDE

1

Ireland ALDE

Against (1)

1

Spain ALDE

Abstain (1)

2
icon: NI NI
24

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4

Belgium NI

3

Czechia NI

1

Austria NI

For (1)

Against (1)

2

Slovakia NI

2

Italy NI

Abstain (1)

3
icon: UEN UEN
22

Denmark UEN

Against (1)

1

Lithuania UEN

2

Ireland UEN

3
icon: IND/DEM IND/DEM
31

Sweden IND/DEM

3

Denmark IND/DEM

Abstain (1)

1

Czechia IND/DEM

1

Netherlands IND/DEM

2

Ireland IND/DEM

Against (1)

1
icon: GUE/NGL GUE/NGL
34

United Kingdom GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

Finland GUE/NGL

Against (1)

1

France GUE/NGL

Against (1)

1

Portugal GUE/NGL

Abstain (1)

3

Netherlands GUE/NGL

Against (1)

1

Cyprus GUE/NGL

2

Ireland GUE/NGL

Against (1)

1

Spain GUE/NGL

Against (1)

1
icon: Verts/ALE Verts/ALE
38

United Kingdom Verts/ALE

5

Sweden Verts/ALE

Against (1)

1

Finland Verts/ALE

Against (1)

1

Denmark Verts/ALE

Against (1)

1

Belgium Verts/ALE

2

Austria Verts/ALE

2

Latvia Verts/ALE

Against (1)

1

Luxembourg Verts/ALE

Against (1)

1

Italy Verts/ALE

Against (1)

1
icon: PPE-DE PPE-DE
237
3

Denmark PPE-DE

For (1)

1

Estonia PPE-DE

Against (1)

1

Lithuania PPE-DE

2

Malta PPE-DE

Against (2)

2

Austria PPE-DE

Abstain (1)

5

Slovenia PPE-DE

4

Latvia PPE-DE

3

Cyprus PPE-DE

2

Luxembourg PPE-DE

3

Ireland PPE-DE

For (1)

5

RC B6-0551/2005 - Biotechnologies - am. 5 #

2005/10/26 Outcome: -: 291, +: 279, 0: 63
GB SE BE FI DK CZ EE LT NL EL MT PT FR AT SI CY LV SK IE LU HU ES IT PL DE
Total
70
17
21
13
12
24
6
12
23
22
5
20
68
17
6
5
9
13
11
6
19
47
53
50
84
icon: PSE PSE
173

Czechia PSE

2

Lithuania PSE

2

Slovenia PSE

For (1)

1

Ireland PSE

1

Luxembourg PSE

For (1)

1
icon: ALDE ALDE
76

Sweden ALDE

Against (1)

2
4

Estonia ALDE

2

Austria ALDE

Against (1)

1

Slovenia ALDE

1

Cyprus ALDE

For (1)

1

Latvia ALDE

1

Ireland ALDE

Against (1)

1

Luxembourg ALDE

Against (1)

1

Hungary ALDE

1

Spain ALDE

Abstain (1)

1
icon: NI NI
26

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4

Czechia NI

1

Austria NI

Against (1)

Abstain (1)

2

Slovakia NI

2

Italy NI

3
icon: GUE/NGL GUE/NGL
34

United Kingdom GUE/NGL

Abstain (1)

1

Sweden GUE/NGL

Abstain (1)

1

Finland GUE/NGL

Abstain (1)

1

Netherlands GUE/NGL

Abstain (1)

1

Portugal GUE/NGL

3

France GUE/NGL

Abstain (1)

1

Cyprus GUE/NGL

Against (1)

2

Ireland GUE/NGL

Abstain (1)

1

Spain GUE/NGL

Abstain (1)

1
icon: UEN UEN
21

Denmark UEN

Against (1)

1

Lithuania UEN

2

Ireland UEN

3
icon: IND/DEM IND/DEM
30

Sweden IND/DEM

3

Denmark IND/DEM

1

Czechia IND/DEM

1

Netherlands IND/DEM

2
icon: Verts/ALE Verts/ALE
36

United Kingdom Verts/ALE

4

Sweden Verts/ALE

Against (1)

1

Belgium Verts/ALE

Against (1)

1

Finland Verts/ALE

Against (1)

1

Denmark Verts/ALE

Against (1)

1

Austria Verts/ALE

2

Latvia Verts/ALE

Against (1)

1

Luxembourg Verts/ALE

Against (1)

1

Italy Verts/ALE

Against (1)

1
icon: PPE-DE PPE-DE
237
3

Denmark PPE-DE

For (1)

1

Estonia PPE-DE

Against (1)

1

Lithuania PPE-DE

2

Malta PPE-DE

Against (2)

2

Austria PPE-DE

Abstain (1)

5

Slovenia PPE-DE

4

Cyprus PPE-DE

2

Latvia PPE-DE

3

Ireland PPE-DE

For (1)

5

Luxembourg PPE-DE

3

RC B6-0551/2005 - Biotechnologies - am. 20 #

2005/10/26 Outcome: -: 510, +: 99, 0: 21
CY AT LU IE MT SI EE DK LV FI NL LT CZ SE SK BE PT EL HU PL IT ES FR GB DE
Total
5
17
6
11
5
6
6
12
9
13
23
12
24
17
13
23
20
22
19
49
59
44
64
68
83
icon: Verts/ALE Verts/ALE
37

Austria Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Denmark Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Finland Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Italy Verts/ALE

1

United Kingdom Verts/ALE

5
icon: GUE/NGL GUE/NGL
35

Cyprus GUE/NGL

2

Ireland GUE/NGL

1

Finland GUE/NGL

For (1)

1

Netherlands GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Portugal GUE/NGL

3

Spain GUE/NGL

For (1)

1

France GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1
icon: NI NI
26

Austria NI

2

Czechia NI

Abstain (1)

1

Slovakia NI

2

Italy NI

For (1)

Against (1)

Abstain (1)

3

United Kingdom NI

Against (2)

4
icon: IND/DEM IND/DEM
28

Ireland IND/DEM

For (1)

1

Denmark IND/DEM

1

Netherlands IND/DEM

2

Czechia IND/DEM

Against (1)

1

Sweden IND/DEM

3
icon: UEN UEN
21

Ireland UEN

2

Denmark UEN

Against (1)

1

Lithuania UEN

2
icon: ALDE ALDE
79

Cyprus ALDE

Against (1)

1

Austria ALDE

1

Luxembourg ALDE

Against (1)

1

Ireland ALDE

Against (1)

1

Slovenia ALDE

Against (1)

1

Estonia ALDE

Against (2)

2

Denmark ALDE

Abstain (1)

4

Latvia ALDE

Against (1)

1

Sweden ALDE

2

Hungary ALDE

Against (1)

1
2
icon: PSE PSE
167

Luxembourg PSE

Against (1)

1

Ireland PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Finland PSE

3

Lithuania PSE

2

Czechia PSE

2

Slovakia PSE

3
icon: PPE-DE PPE-DE
237

Cyprus PPE-DE

2

Austria PPE-DE

Abstain (1)

5

Luxembourg PPE-DE

3

Malta PPE-DE

Against (2)

2

Slovenia PPE-DE

4

Estonia PPE-DE

Against (1)

1

Denmark PPE-DE

Against (1)

1

Latvia PPE-DE

3

Finland PPE-DE

3

Lithuania PPE-DE

2

RC B6-0551/2005 - Biotechnologies - am. 21 #

2005/10/26 Outcome: -: 518, +: 98, 0: 20
CY AT LU MT SI EE IE DK LV FI SE NL CZ SK LT BE PT EL HU PL FR IT ES GB DE
Total
5
17
6
5
6
6
11
12
9
13
17
23
24
13
12
23
20
23
19
50
66
58
45
70
83
icon: Verts/ALE Verts/ALE
37

Austria Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Denmark Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Finland Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Italy Verts/ALE

1

Spain Verts/ALE

2

United Kingdom Verts/ALE

5
icon: GUE/NGL GUE/NGL
34

Cyprus GUE/NGL

2

Ireland GUE/NGL

1

Finland GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Netherlands GUE/NGL

For (1)

1

Portugal GUE/NGL

3

France GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1
icon: NI NI
25

Austria NI

2

Czechia NI

Abstain (1)

1

Slovakia NI

2

Italy NI

For (1)

Abstain (1)

2

United Kingdom NI

Against (2)

4
icon: IND/DEM IND/DEM
28

Ireland IND/DEM

For (1)

1

Denmark IND/DEM

1

Sweden IND/DEM

3

Netherlands IND/DEM

2

Czechia IND/DEM

Against (1)

1
icon: UEN UEN
21

Ireland UEN

2

Denmark UEN

Against (1)

1

Lithuania UEN

2
icon: ALDE ALDE
79

Cyprus ALDE

Against (1)

1

Austria ALDE

1

Luxembourg ALDE

Against (1)

1

Slovenia ALDE

Against (1)

1

Estonia ALDE

Against (2)

2

Ireland ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4

Latvia ALDE

Against (1)

1

Sweden ALDE

2

Hungary ALDE

Against (1)

1

Spain ALDE

Against (1)

1
icon: PSE PSE
175

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Ireland PSE

Against (1)

1

Finland PSE

3

Czechia PSE

2

Slovakia PSE

3

Lithuania PSE

2
icon: PPE-DE PPE-DE
237

Cyprus PPE-DE

2

Austria PPE-DE

Abstain (1)

5

Luxembourg PPE-DE

3

Malta PPE-DE

Against (2)

2

Slovenia PPE-DE

4

Estonia PPE-DE

Against (1)

1

Denmark PPE-DE

Against (1)

1

Latvia PPE-DE

3

Finland PPE-DE

3

Lithuania PPE-DE

2

RC B6-0551/2005 - Biotechnologies - am. 15 #

2005/10/26 Outcome: -: 474, +: 123, 0: 42
CY LU IE LV EE MT AT SE SI LT DK FI BE NL SK CZ PT FR EL IT HU ES PL GB DE
Total
5
6
12
9
5
5
17
17
6
12
12
13
23
23
13
24
19
70
23
56
19
47
50
70
83
icon: Verts/ALE Verts/ALE
37

Luxembourg Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Austria Verts/ALE

2

Sweden Verts/ALE

For (1)

1

Denmark Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Italy Verts/ALE

1

United Kingdom Verts/ALE

5
icon: GUE/NGL GUE/NGL
34

Cyprus GUE/NGL

2

Ireland GUE/NGL

1

Sweden GUE/NGL

1

Finland GUE/NGL

For (1)

1

Netherlands GUE/NGL

For (1)

1

Portugal GUE/NGL

3

France GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1
icon: NI NI
26

Austria NI

2

Slovakia NI

Abstain (1)

2

Czechia NI

Abstain (1)

1

Italy NI

Abstain (1)

3

United Kingdom NI

Abstain (1)

4
icon: IND/DEM IND/DEM
31

Ireland IND/DEM

For (1)

1

Sweden IND/DEM

3

Denmark IND/DEM

1

Netherlands IND/DEM

2

Czechia IND/DEM

Abstain (1)

1
icon: UEN UEN
22

Ireland UEN

3

Lithuania UEN

Against (1)

Abstain (1)

2

Denmark UEN

Against (1)

1
icon: ALDE ALDE
78

Cyprus ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Ireland ALDE

For (1)

1

Latvia ALDE

Against (1)

1

Estonia ALDE

Against (2)

2

Austria ALDE

1

Sweden ALDE

2

Slovenia ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4

Hungary ALDE

Against (1)

1

Spain ALDE

Abstain (1)

2
icon: PSE PSE
174

Luxembourg PSE

Against (1)

1

Ireland PSE

Against (1)

1

Estonia PSE

2

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Finland PSE

3

Slovakia PSE

3

Czechia PSE

2
icon: PPE-DE PPE-DE
237

Cyprus PPE-DE

2

Luxembourg PPE-DE

3

Latvia PPE-DE

3

Estonia PPE-DE

Against (1)

1

Malta PPE-DE

Against (2)

2

Austria PPE-DE

Abstain (1)

5

Slovenia PPE-DE

4

Lithuania PPE-DE

2

Denmark PPE-DE

Against (1)

1

Finland PPE-DE

3

RC B6-0551/2005 - Biotechnologies - am. 16 #

2005/10/26 Outcome: -: 509, +: 96, 0: 33
CY LU MT AT SI EE DK LV IE FI SE NL SK LT PT CZ BE EL HU PL FR ES IT GB DE
Total
5
6
5
17
6
6
12
9
12
13
17
23
13
12
19
24
23
22
18
51
70
47
55
69
84
icon: Verts/ALE Verts/ALE
38

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Finland Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Italy Verts/ALE

1

United Kingdom Verts/ALE

5
icon: GUE/NGL GUE/NGL
34

Cyprus GUE/NGL

2

Ireland GUE/NGL

1

Finland GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Netherlands GUE/NGL

For (1)

1

Portugal GUE/NGL

3

France GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1
icon: IND/DEM IND/DEM
31

Denmark IND/DEM

1

Ireland IND/DEM

For (1)

1

Sweden IND/DEM

3

Netherlands IND/DEM

2

Czechia IND/DEM

Against (1)

1
icon: NI NI
25

Austria NI

2

Slovakia NI

2

Czechia NI

Abstain (1)

1

Italy NI

For (1)

Abstain (1)

2

United Kingdom NI

Abstain (1)

4
icon: UEN UEN
22

Denmark UEN

Against (1)

1

Ireland UEN

3

Lithuania UEN

2
icon: ALDE ALDE
79

Cyprus ALDE

Against (1)

1

Luxembourg ALDE

Against (1)

1

Austria ALDE

1

Slovenia ALDE

Against (1)

1

Estonia ALDE

Against (2)

2

Denmark ALDE

Abstain (1)

4

Latvia ALDE

Against (1)

1

Ireland ALDE

Against (1)

1

Sweden ALDE

2

Hungary ALDE

Against (1)

1
2
icon: PSE PSE
173

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Ireland PSE

Against (1)

1

Finland PSE

3

Slovakia PSE

3

Lithuania PSE

2

Czechia PSE

2
icon: PPE-DE PPE-DE
236

Cyprus PPE-DE

2

Luxembourg PPE-DE

3

Malta PPE-DE

Against (2)

2

Austria PPE-DE

Abstain (1)

5

Slovenia PPE-DE

4

Estonia PPE-DE

Against (1)

1

Denmark PPE-DE

Against (1)

1

Latvia PPE-DE

3

Finland PPE-DE

3

Lithuania PPE-DE

2

RC B6-0551/2005 - Biotechnologies - cons. M #

2005/10/26 Outcome: +: 349, -: 256, 0: 33
DE PL IT FR IE LV ES SK HU LU EL CY NL SI PT LT AT FI CZ MT BE DK SE EE GB
Total
82
51
59
69
12
9
47
13
19
6
23
5
23
6
17
12
17
13
23
5
23
12
17
6
69
icon: PPE-DE PPE-DE
235

Ireland PPE-DE

Against (1)

5

Luxembourg PPE-DE

3

Cyprus PPE-DE

2
2
3

Malta PPE-DE

2

Denmark PPE-DE

For (1)

1

Estonia PPE-DE

For (1)

1
icon: Verts/ALE Verts/ALE
37

Italy Verts/ALE

1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Finland Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5
icon: UEN UEN
23

Ireland UEN

3

Lithuania UEN

2

Denmark UEN

For (1)

1
icon: IND/DEM IND/DEM
31

Ireland IND/DEM

For (1)

1

Netherlands IND/DEM

2

Czechia IND/DEM

Abstain (1)

1

Denmark IND/DEM

1

Sweden IND/DEM

Against (1)

3
icon: NI NI
26

Italy NI

For (1)

Against (1)

Abstain (1)

3

Slovakia NI

Abstain (1)

2

Austria NI

2

Czechia NI

1

United Kingdom NI

For (1)

Against (2)

Abstain (1)

4
icon: GUE/NGL GUE/NGL
33

France GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

Abstain (1)

1

Spain GUE/NGL

For (1)

1

Cyprus GUE/NGL

2

Netherlands GUE/NGL

Against (1)

1

Portugal GUE/NGL

2

Finland GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

United Kingdom GUE/NGL

1
icon: ALDE ALDE
79

Ireland ALDE

For (1)

1

Latvia ALDE

Against (1)

1

Spain ALDE

Abstain (1)

2

Hungary ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Cyprus ALDE

Against (1)

1

Slovenia ALDE

Against (1)

1

Austria ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4

Sweden ALDE

2

Estonia ALDE

Against (2)

2
icon: PSE PSE
174

Ireland PSE

Against (1)

1

Slovakia PSE

3

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Finland PSE

3

Czechia PSE

2

RC B6-0551/2005 - Biotechnologies - résolution #

2005/10/26 Outcome: +: 338, -: 272, 0: 35
DE PL IT FR IE ES SK LV HU LU CY AT SI LT NL CZ MT EL BE PT DK EE SE FI GB
Total
84
51
59
69
12
48
13
9
19
6
5
17
6
12
23
24
5
23
23
19
12
6
17
13
70
icon: PPE-DE PPE-DE
238

Ireland PPE-DE

Against (1)

5

Luxembourg PPE-DE

3

Cyprus PPE-DE

2
2

Malta PPE-DE

2

Denmark PPE-DE

For (1)

1

Estonia PPE-DE

For (1)

1

Finland PPE-DE

For (1)

3
icon: Verts/ALE Verts/ALE
38

Italy Verts/ALE

1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

2

Belgium Verts/ALE

Abstain (1)

2

Denmark Verts/ALE

For (1)

1

Sweden Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5
icon: UEN UEN
23

Ireland UEN

3

Lithuania UEN

2

Denmark UEN

Abstain (1)

1
icon: NI NI
25

Italy NI

Against (1)

3

Slovakia NI

2

Austria NI

2

Czechia NI

1

United Kingdom NI

For (1)

Abstain (1)

4
icon: IND/DEM IND/DEM
31

Ireland IND/DEM

For (1)

1

Netherlands IND/DEM

2

Czechia IND/DEM

1

Denmark IND/DEM

1

Sweden IND/DEM

3
icon: GUE/NGL GUE/NGL
35

France GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

1

Spain GUE/NGL

For (1)

1

Cyprus GUE/NGL

2

Netherlands GUE/NGL

Abstain (1)

1

Portugal GUE/NGL

For (1)

Against (1)

Abstain (1)

3

Sweden GUE/NGL

Abstain (1)

1

Finland GUE/NGL

Against (1)

1

United Kingdom GUE/NGL

1
icon: ALDE ALDE
79

Ireland ALDE

For (1)

1

Spain ALDE

Abstain (1)

2

Latvia ALDE

Against (1)

1

Hungary ALDE

Against (1)

1

Luxembourg ALDE

For (1)

1

Cyprus ALDE

Against (1)

1

Austria ALDE

1

Slovenia ALDE

Against (1)

1

Denmark ALDE

Abstain (1)

4

Estonia ALDE

Against (2)

2

Sweden ALDE

2
icon: PSE PSE
176

Ireland PSE

Against (1)

1

Slovakia PSE

3

Luxembourg PSE

Against (1)

1

Slovenia PSE

Against (1)

1

Lithuania PSE

2

Czechia PSE

2

Finland PSE

3

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0551_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0551_EN.html
docs/1/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0552_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0552_EN.html
docs/2/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0553_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0553_EN.html
docs/3/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0554_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0554_EN.html
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0555_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0555_EN.html
docs/5/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0556_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0556_EN.html
docs/6/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-6-2005-0557_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-6-2005-0557_EN.html
docs/7/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/RC-6-2005-0551_EN.html
New
https://www.europarl.europa.eu/doceo/document/RC-6-2005-0551_EN.html
docs/8/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/TA-6-2005-0407_EN.html
New
https://www.europarl.europa.eu/doceo/document/TA-6-2005-0407_EN.html
events/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20051025&type=CRE
New
https://www.europarl.europa.eu/doceo/document/EN&reference=20051025&type=CRE
events/2
date
2005-10-26T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-6-2005-0407_EN.html title: T6-0407/2005
summary
events/2
date
2005-10-26T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-6-2005-0407_EN.html title: T6-0407/2005
summary
procedure/legal_basis/0
Rules of Procedure EP 132-p2
procedure/legal_basis/0
Rules of Procedure EP 123-p2
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-551&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0551_EN.html
docs/1/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-552&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0552_EN.html
docs/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-553&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0553_EN.html
docs/3/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-554&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0554_EN.html
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-555&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0555_EN.html
docs/5/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-556&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0556_EN.html
docs/6/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-557&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-6-2005-0557_EN.html
docs/7/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=P6-RC-2005-551&language=EN
New
http://www.europarl.europa.eu/doceo/document/RC-6-2005-0551_EN.html
docs/8
date
2005-10-26T00:00:00
docs
summary
type
Text adopted by Parliament, topical subjects
body
EP
docs/8
date
2005-10-26T00:00:00
docs
summary
type
Text adopted by Parliament, topical subjects
body
EP
events/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P6-TA-2005-407
New
http://www.europarl.europa.eu/doceo/document/TA-6-2005-0407_EN.html
activities
  • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20051025&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 2005-10-26T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=12392&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P6-TA-2005-407 type: Decision by Parliament, 1st reading/single reading title: T6-0407/2005 body: EP type: Results of vote in Parliament
committees
    docs
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-551&language=EN title: B6-0551/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-552&language=EN title: B6-0552/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-553&language=EN title: B6-0553/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-554&language=EN title: B6-0554/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-555&language=EN title: B6-0555/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-556&language=EN title: B6-0556/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2005-557&language=EN title: B6-0557/2005 type: Motion for a resolution body: EP
    • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=P6-RC-2005-551&language=EN title: RC-B6-0551/2005 type: Joint motion for resolution
    • date: 2005-10-26T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P6-TA-2005-407 title: T6-0407/2005 url: http://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2006:272E:SOM:EN:HTML title: OJ C 272 09.11.2006, p. 0274-0440 E summary: The European Parliament adopted a resolution on patents for biotechnological inventions and expressed its s upport for biotechnology as a future technology. An appropriate political framework is important to support this technology, also taking account of ethical, environmental and health aspects. The patenting of biotechnological inventions in accordance with common rules throughout Europe is an important precondition for the provision in Europe of appropriate support for this future technology. Parliament stated that it supported further stem-cell research and other alternatives to promote human health. It did, however, underline its fundamental position regarding the application of biotechnology to human beings, especially the rejection of interventions in the human germ line, the rejection of cloning of the human being in all phases of its development and the rejection of research on human embryos, which destroys the embryo. Directive 98/44/EC provides the framework for this in most cases, but it still leaves important questions open, such as the patenting of human DNA. Parliament called on the European Patent Office and the Member States to grant patents on human DNA only in connection with a concrete application and for the scope of the patent to be limited to this concrete application so that other users can use and patent the same DNA sequence for other applications (purpose-bound protection). The Commission must examine whether this interpretation of the Directive can be achieved by means of a recommendation to the Member States or whether it requires an amendment to the Directive. Parliament went on to recall that the European Patent Office granted a patent on 2 February 2005 (EP1257168) that includes a method of selection of human germ cells and of the germ cells themselves. Opposition has been made to this decision, so that the legal situation is still unclear. Parliament pointed out that germ cells are not patentable as part of the human body and certainly not an invention, and that patent EP1257168 therefore constitutes an infringement of the Directive. It asked the Commission to file a notice of opposition to patent EP1257168 without delay. It called on the European Patent Office, the Commission and the competent authorities in the Member States to work together with Parliament to confirm that all kinds of human cloning are excluded from patenting under the Directive. Parliament insisted that the creation of human embryonic stem cells implies the destruction of human embryos and that therefore the patenting of procedures involving human embryonic stem cells or cells that are grown from human embryonic stem cells is a violation of Article 6(2(c) of the Directive. The European Patent Office is asked to set up a further body which, because of the sensitivity of the issue, checks patents that are sensitive from an ethical point of view before they are granted . type: Text adopted by Parliament, topical subjects body: EP
    events
    • date: 2005-10-25T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20051025&type=CRE title: Debate in Parliament
    • date: 2005-10-26T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=12392&l=en title: Results of vote in Parliament
    • date: 2005-10-26T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P6-TA-2005-407 title: T6-0407/2005 summary: The European Parliament adopted a resolution on patents for biotechnological inventions and expressed its s upport for biotechnology as a future technology. An appropriate political framework is important to support this technology, also taking account of ethical, environmental and health aspects. The patenting of biotechnological inventions in accordance with common rules throughout Europe is an important precondition for the provision in Europe of appropriate support for this future technology. Parliament stated that it supported further stem-cell research and other alternatives to promote human health. It did, however, underline its fundamental position regarding the application of biotechnology to human beings, especially the rejection of interventions in the human germ line, the rejection of cloning of the human being in all phases of its development and the rejection of research on human embryos, which destroys the embryo. Directive 98/44/EC provides the framework for this in most cases, but it still leaves important questions open, such as the patenting of human DNA. Parliament called on the European Patent Office and the Member States to grant patents on human DNA only in connection with a concrete application and for the scope of the patent to be limited to this concrete application so that other users can use and patent the same DNA sequence for other applications (purpose-bound protection). The Commission must examine whether this interpretation of the Directive can be achieved by means of a recommendation to the Member States or whether it requires an amendment to the Directive. Parliament went on to recall that the European Patent Office granted a patent on 2 February 2005 (EP1257168) that includes a method of selection of human germ cells and of the germ cells themselves. Opposition has been made to this decision, so that the legal situation is still unclear. Parliament pointed out that germ cells are not patentable as part of the human body and certainly not an invention, and that patent EP1257168 therefore constitutes an infringement of the Directive. It asked the Commission to file a notice of opposition to patent EP1257168 without delay. It called on the European Patent Office, the Commission and the competent authorities in the Member States to work together with Parliament to confirm that all kinds of human cloning are excluded from patenting under the Directive. Parliament insisted that the creation of human embryonic stem cells implies the destruction of human embryos and that therefore the patenting of procedures involving human embryonic stem cells or cells that are grown from human embryonic stem cells is a violation of Article 6(2(c) of the Directive. The European Patent Office is asked to set up a further body which, because of the sensitivity of the issue, checks patents that are sensitive from an ethical point of view before they are granted .
    • date: 2005-10-26T00:00:00 type: End of procedure in Parliament body: EP
    links
    other
      procedure/legal_basis/0
      Rules of Procedure EP 123-p2
      procedure/legal_basis/0
      Rules of Procedure of the European Parliament EP 123-p2
      procedure/subject
      Old
      • 3.50.16 Industrial property, European patent, Community patent, design and pattern
      • 4.20.02.04 Genetics and bioethics
      New
      3.50.16
      Industrial property, European patent, Community patent, design and pattern
      4.20.02.04
      Genetics and bioethics
      procedure/subtype
      Old
      Resolution on statements
      New
      Resolution on statement
      activities
      • date: 2005-10-25T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20051025&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
      • date: 2005-10-26T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=12392&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P6-TA-2005-407 type: Decision by Parliament, 1st reading/single reading title: T6-0407/2005 body: EP type: Results of vote in Parliament
      committees
        links
        other
          procedure
          reference
          2005/2621(RSP)
          title
          Resolution on patents for biotechnological inventions
          legal_basis
          Rules of Procedure of the European Parliament EP 123-p2
          stage_reached
          Procedure completed
          subtype
          Resolution on statements
          type
          RSP - Resolutions on topical subjects
          subject